ROYAL BANK OF CANADA - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$353,000
+99.4%
3,462
+77.4%
0.00%
Q1 2023$177,000
-0.6%
1,951
-58.3%
0.00%
Q4 2022$178,000
+790.0%
4,677
+464.2%
0.00%
Q3 2022$20,000
+122.2%
829
+185.9%
0.00%
Q2 2022$9,000
-83.9%
290
-83.0%
0.00%
Q1 2022$56,000
-62.2%
1,708
-69.5%
0.00%
Q4 2021$148,000
-51.5%
5,605
+84.6%
0.00%
Q3 2021$305,000
+12.5%
3,037
+58.9%
0.00%
Q2 2021$271,000
-81.5%
1,911
-87.0%
0.00%
Q1 2021$1,462,000
+2658.5%
14,667
+3318.9%
0.00%
Q4 2020$53,000
+140.9%
429
+90.7%
0.00%
Q3 2020$22,000
-98.9%
225
-98.3%
0.00%
-100.0%
Q2 2020$2,040,000
+100.8%
13,074
+85.7%
0.00%
Q1 2020$1,016,000
+936.7%
7,039
+1375.7%
0.00%
Q4 2019$98,000
+512.5%
477
+138.5%
0.00%
Q3 2019$16,000
-57.9%
200
-50.5%
0.00%
Q2 2019$38,000
-19.1%
404
-27.1%
0.00%
Q1 2019$47,000
+56.7%
554
+4.1%
0.00%
Q4 2018$30,000
-57.7%
532
-38.8%
0.00%
Q3 2018$71,000
+294.4%
869
+61.2%
0.00%
Q2 2018$18,000
+800.0%
539
+433.7%
0.00%
Q1 2018$2,000
-50.0%
101
-21.1%
0.00%
Q4 2017$4,000
-88.6%
128
-88.7%
0.00%
Q3 2017$35,000
+1650.0%
1,131
+1613.6%
0.00%
Q2 2017$2,000
-50.0%
66
-66.2%
0.00%
Q1 2017$4,000
+300.0%
195
+375.6%
0.00%
Q4 2016$1,000410.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders